EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations

Malik Olatunde Oduoye iD, Muhammad Usman Haider, Mohammed Dheyaa Marsool Marsool iD, Mayowa Odunayo Kareem iD, Adenike Ebunoluwa Adedayo iD, Abdulkarim Surajo Abdulkarim iD, Abdullahi Adeyemi Adegoke iD, Ikshwaki Kaushik iD, Hamza Irfan iD, Hassan Abdullahi Yusuf iD, Hussain Haider Shah, Karim Arif Karim iD

Health Science Reports · 2024-01 · 7 (1)

DOI: 10.1002/hsr2.1797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 04.01.2024. Verfasst von Malik Olatunde Oduoye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education/Research Medical Research Circle (MedReC) Bukavu Congo. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mass malaria vaccination, rather than vaccinating only children below age 5, has been proven to have the potential to reduce morbidity and mortality among those vaccinated, both young and old. Addressing vaccine scepticism and misinformation is crucial in African nations to build public trust in malaria prevention. Therefore, including a wider range of demographics in vaccine trials is necessary for equitable representation and achieving herd immunity against malaria.

Aim

This present article aims to identify some of the obstacles that impede malaria vaccination usage and acceptability in African Nations in combating malaria in the region as it continues to pose a significant global public health problem. Methodology A literature search was done on the Malaria vaccine between 2000 and 2023. Past and present articles/studies on this topic were consulted on PubMed, Google Scholar, Scopus and Web of Science using the following keywords; “Malaria,” “Vaccines,” “African Nations,” “Obstacles, Strategies,” and “Public Health.” Results The recently approved RTS, S/AS01, and R21/Matrix‐M™ Malaria vaccines have the potential to prevent numerous deaths and cases of Malaria in Africa. These vaccines Malaria vaccines are cost‐effective in African areas with moderate to high plasmodium falciparum and can be delivered through routine immunization.

Conclusion

To combat malaria effectively in African Nations, African leaders need to set up a comprehensive approach that involves; prevention, healthcare access, implementation research strategies towards adoption and acceptance of malaria vaccines in Africa as well as community engagement with the religious leaders, the market women, community heads, schools, as well as students’ union towards the willingness and acceptability of the malaria vaccines among the African populations.

Schlagwörter

Stichwörter der Autor:innen

African Nationsmalariaobstaclespublic healthstrategiesvaccines

Autor:innen und Institutionen

  • Department of Medical Education/Research Medical Research Circle (MedReC) Bukavu Congo.
  • Department of Internal Medicine, Mayo Hospital Lahore King Edward Medical University Lahore Lahore Pakistan.
  • Department of Internal Medicine, Al-Kindy College of Medicine University of Baghdad Baghdad Iraq.
  • Department of Internal Medicine Babcock University Teaching Hospital Ilishan-Remo Ogun State Nigeria.
  • Department of Internal Medicine University of Debrecen Debrecen Hungary.
  • Department of Medicine and Surgery, College of Health Sciences Bayero University Kano Kano State Nigeria.

ORCID-Profile: Malik Olatunde Oduoye, Mohammed Dheyaa Marsool Marsool, Mayowa Odunayo Kareem, Adenike Ebunoluwa Adedayo, Abdulkarim Surajo Abdulkarim, Abdullahi Adeyemi Adegoke, Ikshwaki Kaushik, Hamza Irfan, Hassan Abdullahi Yusuf, Karim Arif Karim

Zitieren

APA

Oduoye, M. O., Haider, M. U., Marsool, M. D. M., Kareem, M. O., Adedayo, A. E., Abdulkarim, A. S., Adegoke, A. A., Kaushik, I., Irfan, H., Yusuf, H. A., Shah, H. H., & Karim, K. A. (2024). Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations. Health Science Reports, 7(1). https://doi.org/10.1002/hsr2.1797

Vancouver

Oduoye MO, Haider MU, Marsool MDM, Kareem MO, Adedayo AE, Abdulkarim AS, et al. Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations. Health Science Reports. 2024;7(1). doi:10.1002/hsr2.1797

BibTeX
@article{Oduoye2024,
  author = {Oduoye, Malik Olatunde and Haider, Muhammad Usman and Marsool, Mohammed Dheyaa Marsool and Kareem, Mayowa Odunayo and Adedayo, Adenike Ebunoluwa and Abdulkarim, Abdulkarim Surajo and Adegoke, Abdullahi Adeyemi and Kaushik, Ikshwaki and Irfan, Hamza and Yusuf, Hassan Abdullahi and Shah, Hussain Haider and Karim, Karim Arif},
  title = {Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations},
  journal = {Health Science Reports},
  year = {2024},
  volume = {7},
  number = {1},
  doi = {10.1002/hsr2.1797}
}
Kostenlos starten →